Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has announced the forthcoming retirement of their long-serving Non-Executive Director Brenda Shanahan, coupled with the appointment of three new Non-Executive Directors. Matthew Pringle, Guy van Dievoet, and Dr. Pearl Grimes will join the board, bringing a wealth of experience in corporate finance, investment banking, and dermatology. These changes are part of a board renewal process that will see further shifts in committee memberships.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
